Subsequent research by the same group has shown that serum from patients carrying PRKN/PINK1 biallelic mutation had increased levels of pro-inflammatory interleukin-6 (IL6) and circulating cell-free mtDNA pointing at a role of STING-mediated inflammation in the pathogenicity of human PD [90]. The gene discussed is STING1; the disease is Parkinson disease.